Akane Inoue

748 total citations
8 papers, 594 citations indexed

About

Akane Inoue is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Akane Inoue has authored 8 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Neurology and 2 papers in Oncology. Recurrent topics in Akane Inoue's work include Ion channel regulation and function (3 papers), Muscle Physiology and Disorders (3 papers) and Myasthenia Gravis and Thymoma (2 papers). Akane Inoue is often cited by papers focused on Ion channel regulation and function (3 papers), Muscle Physiology and Disorders (3 papers) and Myasthenia Gravis and Thymoma (2 papers). Akane Inoue collaborates with scholars based in Japan and United States. Akane Inoue's co-authors include Yuji Yamanashi, Yoichiro Iwakura, Osamu Higuchi, Kumiko Okada, Shigeru Kakuta, Tetsu Akiyama, Masakatsu Motomura, Katsumi Eguchi, Yoji Murata and Hirokazu Shiraishi and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Akane Inoue

8 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akane Inoue Japan 6 357 179 130 129 72 8 594
Peter T. Hallock United States 7 518 1.5× 291 1.6× 209 1.6× 205 1.6× 13 0.2× 7 804
Hayley Spearman United Kingdom 13 376 1.1× 202 1.1× 60 0.5× 116 0.9× 55 0.8× 17 726
Hacer Durmuş Türkiye 15 183 0.5× 327 1.8× 84 0.6× 79 0.6× 47 0.7× 49 594
Jussara Hagen United States 14 604 1.7× 165 0.9× 146 1.1× 91 0.7× 35 0.5× 20 855
Christine S. Morris United Kingdom 9 171 0.5× 230 1.3× 64 0.5× 40 0.3× 99 1.4× 14 532
Hiromichi Mannoji Japan 10 183 0.5× 181 1.0× 51 0.4× 48 0.4× 72 1.0× 22 566
Jean-Michel Vallat France 11 448 1.3× 220 1.2× 371 2.9× 135 1.0× 93 1.3× 13 932
Raimund Fahsold Germany 14 344 1.0× 397 2.2× 85 0.7× 50 0.4× 52 0.7× 27 777
C. Semino–Mora United States 8 484 1.4× 152 0.8× 154 1.2× 243 1.9× 41 0.6× 9 805
Jennifer J. Tung United States 5 260 0.7× 96 0.5× 51 0.4× 82 0.6× 14 0.2× 8 444

Countries citing papers authored by Akane Inoue

Since Specialization
Citations

This map shows the geographic impact of Akane Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akane Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akane Inoue more than expected).

Fields of papers citing papers by Akane Inoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akane Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akane Inoue. The network helps show where Akane Inoue may publish in the future.

Co-authorship network of co-authors of Akane Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Akane Inoue. A scholar is included among the top collaborators of Akane Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akane Inoue. Akane Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Tanabe, Yuko, Wenting Li, Hiroki Shiomi, et al.. (2025). CD157+ vascular endothelial cells derived from human-induced pluripotent stem cells have high angiogenic potential. Inflammation and Regeneration. 45(1). 14–14. 1 indexed citations
2.
Inoue, Akane, Tamotsu Kiyoshima, Keigo Yoshizaki, et al.. (2021). Deletion of epithelial cell-specific p130Cas impairs the maturation stage of amelogenesis. Bone. 154. 116210–116210. 2 indexed citations
3.
Tezuka, Tohru, Akane Inoue, Taisuke Hoshi, et al.. (2014). The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses. Proceedings of the National Academy of Sciences. 111(46). 16556–16561. 48 indexed citations
4.
Kawamata, Aya, Akane Inoue, Hiroaki Hemmi, et al.. (2011). Dok-1 and Dok-2 deficiency induces osteopenia via activation of osteoclasts. Journal of Cellular Physiology. 226(12). 3087–3093. 8 indexed citations
5.
Mashima, Ryuichi, Kazuho Honda, Yi Yang, et al.. (2010). Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive histiocytic sarcoma. Laboratory Investigation. 90(9). 1357–1364. 44 indexed citations
6.
Inoue, Akane, Kiyoko Setoguchi, Kumiko Okada, et al.. (2009). Dok-7 Activates the Muscle Receptor Kinase MuSK and Shapes Synapse Formation. Science Signaling. 2(59). ra7–ra7. 77 indexed citations
7.
Okada, Kumiko, Akane Inoue, Yoji Murata, et al.. (2006). The Muscle Protein Dok-7 Is Essential for Neuromuscular Synaptogenesis. Science. 312(5781). 1802–1805. 337 indexed citations
8.
Shinohara, Hisaaki, Akane Inoue, Noriko Toyama‐Sorimachi, et al.. (2005). Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling. The Journal of Experimental Medicine. 201(3). 333–339. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026